Minerva Neurosciences, Inc.

NASDAQ:NERV

Biotechnology

Healthcare
$2.18 -6.49%

-$0.30 today

Market cap
$108.64M
Beta
-0.11
P/E (TTM)
-0.2
EPS (TTM)
-$8.46
52W Low $1.76High $12.46

Volume 0.28M

Average 0.21M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$15.10M

FY 2025 · Annual

Net Income

-$293.42M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development32.04M14.65M12.71M11.9M5.76M
Selling, General & Admin13.33M10.58M10.41M9.95M9.34M
Operating Expenses45.37M25.23M23.12M21.85M15.1M
Depreciation & Amortization101.79K8.51K30.98K22.47K5.44K
EBITDA(45.28M)(24.69M)(21.69M)6.02M(293.42M)
EBITDA Margin—————
Operating Income(45.37M)(25.23M)(23.12M)(21.85M)(15.1M)
Operating Margin—————
Interest Income16.52K556.95K1.44M1.27M948.12K
Interest Expense6.33M7.41M8.28M4.56M0
Other Income / Expenses(6.34M)(6.88M)(6.89M)23.29M(278.32M)
Income Before Tax(51.71M)(32.11M)(30.01M)1.44M(293.42M)
Pre-Tax Margin—————
Income Tax Expense(1.8M)0000
Net Income(49.91M)(32.11M)(30.01M)1.44M(293.42M)
Net Margin—————
EPS (Basic)(9.35)(6.01)(4.61)0.19(34.67)
EPS (Diluted)(9.35)(6.01)(4.61)0.19(34.67)
Weighted Avg Shares5.34M5.34M6.51M7.57M8.46M
Weighted Avg Shares (Diluted)5.34M5.34M6.51M7.57M8.46M

NERV Earnings Waterfall · TTM

NASDAQ:NERV · Revenue to Net Income

Key Ratios

EPS$-28.87
Gross Margin0.0%
Net Margin0.0%
P/E Ratio0.5
P/S Ratio0.0

Analysis

$0 of revenue converted into -$394.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-28.87, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 6, 2026
10-QQuarterly reportNov 6, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
SC 13GSC 13G filingOct 27, 2026

How much revenue does NERV generate?

Minerva Neurosciences, Inc. (NERV) reported $0.00 of revenue in fiscal 2025.

Is NERV profitable?

Minerva Neurosciences, Inc. (NERV) reported -$293.42M of net income.